Agilent Bond Elut Plexa PCX and Poroshell 120 Opiate Analysis Application Note

This document presents a method for SAMHSA-compliant LC/MS/MS analysis of opiates (morphine and codeine) in urine using Agilent Bond Elut Plexa PCX and Agilent Poroshell 120. The method meets the latest SAMHSA guidelines and demonstrates linearity, limit of detection (LOD), accuracy and precision, as well as measurement of matrix effects, extraction recovery, and overall process efficiency. The document also introduces the Agilent products used and their features.


Agilent Bond Elut Plexa PCX and Poroshell 120 Opiate Analysis Application Note - cover page
Brand
Agilent
Document type
Application Note
Language
English
Pages
8
File format
PDF
File size
214 KB
Published
11 June, 2012
Updated
29 September, 2023
MD5 checksum
81E48B806E05F20EE403029EAB504C6A

About this manual

The document presents a simplified liquid chromatography-tandem mass spectrometry (LC/MS/MS) method designed to meet the guidelines of the US Substance Abuse and Mental Health Services Administration (SAMHSA). The method focuses on the confirmation of opiates, specifically morphine and codeine, in urine samples without requiring derivatization steps. It utilizes Agilent Bond Elut Plexa PCX mixed-mode polymeric solid-phase extraction (SPE) cartridges for sample preparation.

What's inside

  • Introduction
  • Analytes
  • Materials and instrumentation
  • Sample preparation
  • LC/MS/MS conditions
  • Results and Discussion

Frequently asked questions

What is the SAMHSA-established confirmation cutoff concentration for morphine and codeine?

The established confirmation cutoff concentration for morphine and codeine is 2,000 ng/mL.

How long should the sample be incubated in the heating block during hydrolysis?

The sample should be incubated in the heating block at 95 +5 °C for 90 minutes.

Download PDF (214 KB)

More Agilent Manuals


View all Agilent manuals →